Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment
Clinical trial NCT01108705 · TERMINATED
Trial details
- NCT number
- NCT01108705
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-10-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.